Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma

被引:0
|
作者
Yukio Chiba
Tetsuro Taniguchi
Katsuhiko Matsuyama
Masato Sasaki
Yasushi Kato
Hirokazu Tanaka
Ryusuke Muraoka
Nobuhiko Tanigawa
机构
[1] Fukui Medical University,Second Department of Surgery
来源
Surgery Today | 1999年 / 29卷
关键词
angiogenesis; p53; apoptosis; lung adenocarcinoma; hematogenous metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to clarify which factors are important as predictors not only of patient survival but also of hematogenic metastasis in 15 patients with stage I lung adenocarcinoma who underwent curative operation. The relationship between tumor angiogenesis, apoptosis, and p53 oncogene was also studied. A total of 15 patients were divided into two groups: surviving group (n=7) and nonsurviving (metastasis) group (n=8). We studied the medical charts, operative records, pathologic reports, and tumor specimens taken at surgical resection. We measured the apoptotic index using the ApopTag kit and the intratumoral microvessel count using an anti-CD34 monoclonal antibody. In addition, immunohistochemical staining for the expression of p53 was conducted simultaneously. The clinicopathological characteristics, including age, sex, tumor size (pT), and histological differentiation, were not significantly different between the surviving and the nonsurviving group. The microvessel count was significantly higher in nonsurviving group than in the surviving group. The apoptotic index and the expression of p53 was not significantly different between the two groups. An inverse correlation between the apoptotic index and microvessel count, and a positive correlation between the expression of p53 and microvessel count, were observed. Angiogenesis may be an important prognostic factor in patients with stage I lung adenocarcinoma.
引用
收藏
页码:1148 / 1153
页数:5
相关论文
共 50 条
  • [41] Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
    Jose G. Teodoro
    Sara K. Evans
    Michael R. Green
    Journal of Molecular Medicine, 2007, 85 : 1175 - 1186
  • [42] Tumor angiogenesis increases with nuclear p53 accumulation in gastric carcinoma
    Huang, SP
    Wu, MS
    Shun, CT
    Wang, HP
    Lin, JT
    HEPATO-GASTROENTEROLOGY, 2002, 49 (47) : 1453 - 1456
  • [43] APOPTOSIS, CANCER AND THE P53 TUMOR-SUPPRESSOR GENE
    LEE, JM
    BERNSTEIN, A
    CANCER AND METASTASIS REVIEWS, 1995, 14 (02) : 149 - 161
  • [44] RESTORATION OF APOPTOSIS IN P53 DEFICIENT TUMOR-CELLS
    FISHER, DE
    BODIS, S
    LOWE, S
    TAKEMOTO, C
    HOUSMAN, D
    JACKS, T
    BLOOD, 1994, 84 (10) : A111 - A111
  • [45] The metastases of lung cancer to the brain - The examination of angiogenesis and p53 expression
    Rzepko, R
    Izycka-Swieszewska, E
    Borowska-Lehman, J
    FOLIA NEUROPATHOLOGICA, 1999, 37 (03): : 195 - 198
  • [46] Apoptosis, p53, and tumor cell sensitivity to anticancer agents
    Brown, JM
    Wouters, BG
    CANCER RESEARCH, 1999, 59 (07) : 1391 - 1399
  • [47] The role of the tumor suppressor gene p53 in cardiomyocyte apoptosis
    Crow M.T.
    Long X.
    Guglielmi M.B.
    Asai T.
    Lakatta E.G.
    Heart Failure Reviews, 1998, 3 (1) : 45 - 61
  • [48] Transcriptional regulation of apoptosis by the p53 tumor suppressor protein
    Prives, C.
    Tanaka, T.
    Baptiste-Okoh, N.
    Zupnick, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 76 - 76
  • [49] p53 as a prognostic factor for stage III serous adenocarcinoma of the ovary
    Daponte, A
    Guidozi, F
    Tiltman, AJ
    Marineanu, A
    Taylor, L
    ANTICANCER RESEARCH, 1999, 19 (3B) : 2387 - 2389
  • [50] Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer
    Clifford, SL
    Kaminetsky, CP
    Cirisano, FD
    Dodge, R
    Soper, JT
    ClarkePearson, DL
    Berchuck, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (06) : S229 - S232